Overview

The Effect of MDZ on Movement During UIA Clipping

Status:
Not yet recruiting

Trial end date:
2023-12-31

Target enrollment:

Participant gender:

Summary

This study is a randomized, controlled, double-blinded, and parallel design study. A total 64 patients will be randomized to receive midazolam or normal saline during unruptured intracranial aneurysm clipping surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Seoul National University Hospital

Treatments:

Midazolam